Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma

Uncoupling protein-2 (UCP2) controls the antioxidant response and redox homeostasis in cancer and is considered a potent molecular target for cancer treatment. However, the specific mechanism of UCP2 inhibition and its role in glioblastoma...

Full description

Saved in:
Bibliographic Details
Main Authors: Dong Hao, Sun Kaixuan, Wang Xuejie, Cui Meimei, Ma Yaping, Li Kexin, Duan Wanli, Zhang Hongxing, Zhang Liying, Sheng Zhimei, He Maotao, Zhang Baogang
Format: Article
Language:English
Published: China Science Publishing & Media Ltd. 2024-11-01
Series:Acta Biochimica et Biophysica Sinica
Subjects:
Online Access:https://www.sciengine.com/doi/10.3724/abbs.2024168
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850260862042898432
author Dong Hao
Sun Kaixuan
Wang Xuejie
Cui Meimei
Ma Yaping
Li Kexin
Duan Wanli
Zhang Hongxing
Zhang Liying
Sheng Zhimei
He Maotao
Zhang Baogang
author_facet Dong Hao
Sun Kaixuan
Wang Xuejie
Cui Meimei
Ma Yaping
Li Kexin
Duan Wanli
Zhang Hongxing
Zhang Liying
Sheng Zhimei
He Maotao
Zhang Baogang
author_sort Dong Hao
collection DOAJ
description Uncoupling protein-2 (UCP2) controls the antioxidant response and redox homeostasis in cancer and is considered a potent molecular target for cancer treatment. However, the specific mechanism of UCP2 inhibition and its role in glioblastoma (GBM) have not yet been elucidated. Here, we attempt to identify a UCP2 inhibitor and study the underlying molecular mechanism in GBM. Bioinformatics analysis and immunohistochemistry are used to validate the high expression of UCP2 in GBM and its prognostic significance. Drug intervention and tumor xenograft experiments are conducted to determine the inhibitory effect of genipin, a UCP2 inhibitor, on UCP2. The mitochondrial membrane potential and key ferroptosis genes are examined to determine the occurrence of ferroptosis. High expression of UCP2 in GBM is associated with poor prognosis, and inhibiting UCP2 can alleviate the malignant behavior of GBM tumors. Genipin can downregulate the expression of GPX4 and upregulate the expression of ACSL4 by inhibiting UCP2, leading to ferroptosis and alleviating the malignant behavior of tumors. In summary, UCP2 is a potential therapeutic target for GBM. Genipin, which targets UCP2, effectively inhibits GBM development by inducing ferroptosis in vivo and in vitro. These findings indicate that genipin treatment based on UCP2 targeting has potential therapeutic applications with a clinical perspective for the treatment of GBM patients.
format Article
id doaj-art-4c081f2e4b614a79844d220c8808c985
institution OA Journals
issn 1672-9145
language English
publishDate 2024-11-01
publisher China Science Publishing & Media Ltd.
record_format Article
series Acta Biochimica et Biophysica Sinica
spelling doaj-art-4c081f2e4b614a79844d220c8808c9852025-08-20T01:55:33ZengChina Science Publishing & Media Ltd.Acta Biochimica et Biophysica Sinica1672-91452024-11-015740341410.3724/abbs.202416820d259ccRepurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastomaDong Hao0Sun Kaixuan1Wang Xuejie2Cui Meimei3Ma Yaping4Li Kexin5Duan Wanli6Zhang Hongxing7Zhang Liying8Sheng Zhimei9He Maotao10Zhang Baogang11["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China","Department of Pathology, Affiliated Hospital of Shandong Second Medical University, Weifang 261041, China"]["Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang 261042, China"]Uncoupling protein-2 (UCP2) controls the antioxidant response and redox homeostasis in cancer and is considered a potent molecular target for cancer treatment. However, the specific mechanism of UCP2 inhibition and its role in glioblastoma (GBM) have not yet been elucidated. Here, we attempt to identify a UCP2 inhibitor and study the underlying molecular mechanism in GBM. Bioinformatics analysis and immunohistochemistry are used to validate the high expression of UCP2 in GBM and its prognostic significance. Drug intervention and tumor xenograft experiments are conducted to determine the inhibitory effect of genipin, a UCP2 inhibitor, on UCP2. The mitochondrial membrane potential and key ferroptosis genes are examined to determine the occurrence of ferroptosis. High expression of UCP2 in GBM is associated with poor prognosis, and inhibiting UCP2 can alleviate the malignant behavior of GBM tumors. Genipin can downregulate the expression of GPX4 and upregulate the expression of ACSL4 by inhibiting UCP2, leading to ferroptosis and alleviating the malignant behavior of tumors. In summary, UCP2 is a potential therapeutic target for GBM. Genipin, which targets UCP2, effectively inhibits GBM development by inducing ferroptosis in vivo and in vitro. These findings indicate that genipin treatment based on UCP2 targeting has potential therapeutic applications with a clinical perspective for the treatment of GBM patients.https://www.sciengine.com/doi/10.3724/abbs.2024168genipinuncoupling protein-2ferroptosisglioblastomamalignant behavior of tumors
spellingShingle Dong Hao
Sun Kaixuan
Wang Xuejie
Cui Meimei
Ma Yaping
Li Kexin
Duan Wanli
Zhang Hongxing
Zhang Liying
Sheng Zhimei
He Maotao
Zhang Baogang
Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
Acta Biochimica et Biophysica Sinica
genipin
uncoupling protein-2
ferroptosis
glioblastoma
malignant behavior of tumors
title Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
title_full Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
title_fullStr Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
title_full_unstemmed Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
title_short Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
title_sort repurposed genipin targeting ucp2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
topic genipin
uncoupling protein-2
ferroptosis
glioblastoma
malignant behavior of tumors
url https://www.sciengine.com/doi/10.3724/abbs.2024168
work_keys_str_mv AT donghao repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT sunkaixuan repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT wangxuejie repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT cuimeimei repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT mayaping repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT likexin repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT duanwanli repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT zhanghongxing repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT zhangliying repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT shengzhimei repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT hemaotao repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma
AT zhangbaogang repurposedgenipintargetingucp2exhibitsantitumoractivitythroughinducingferroptosisinglioblastoma